Delee

Delee

Early Stage

Blood testing device for early diagnosis of cancer and treatment monitoring

Blood testing device for early diagnosis of cancer and treatment monitoring

Overview

Raised to Date: Raised: $204,059

Total Commitments ($USD)

Platform

Republic

Start Date

06/05/2022

Close Date

12/16/2022

Min. Goal
$25,000
Max. Goal
$4,000,000
Min. Investment

$100

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Early Bird Val. Cap

$19,000,000

Valuation Cap

$22,000,000

Discount

0%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

12/30/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,057

# of Investors

645

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Laredo, Texas

Business Type

Growth

Delee, with a valuation of $22 million, is raising funds on Republic. The company has created a device, CytoCatch, for the early detection of circulating tumor cells in the bloodstream. The device also assists in the personalization and optimization of the treatment of patients and monitors the effectiveness of treatments. Thus, CytoCatch helps to increase the chances of curing cancer and survival. Delee already has a fully functional technology that is being tested for prostate cancer and breast cancer and will start its research use-only sales by Q4 of 2022. Liza Velarde, Juan Felipe Yee, and Alejandro Abarca founded Delee in November 2016. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $4,000,000. The campaign proceeds will be used for the completion of clinical studies, the establishment of multiple collaborations, and commercial launch of the technology.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-444,284

$-714,442

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$75,402

$344,289

Accounts Receivable

$0

$0

Total Assets

$253,337

$455,488

Short-Term Debt

$76,086

$9,896

Long-Term Debt

$0

$0

Total Liabilities

$76,086

$9,896

Financials as of: 06/05/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Delee 12/15/2022 Republic $22,000,000 $204,059 SAFE Funded RegCF
Delee 04/05/2022 StartEngine $22,040,057 $347,498 Equity - Preferred Funded RegCF
Delee 04/23/2020 Republic $10,000,000 $1,070,000 SAFE Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Delee on Republic 2022
Platform: Republic
Security Type: SAFE
Valuation: $22,000,000

Follow company

Follow Delee on Republic 2022

Buy Delee's Deal Report

Warning: according to the close date for this deal, Delee may no longer be accepting investments.

Delee Deal Report

Get KingsCrowd’s comprehensive report on Delee including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Delee is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Delee deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge